Neurofibromatosis type 2 in childhood: a clinical characterization

被引:1
|
作者
Hinojosa-Mateo, Carmen M. [1 ]
Reche-Sainz, Jose A. [2 ]
Hernandez-Nunez, Almudena [3 ]
Ramos-Lopez, Maria [4 ]
Arpa-Fernandez, Ana [5 ]
Natera-de Benito, Daniel [1 ]
机构
[1] Hosp Univ Fuenlabrada, Serv Pediat, Camino Molino 2, E-28942 Madrid, Spain
[2] Hosp Univ Fuenlabrada, Serv Oftalmol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain
[4] Hosp Univ Fuenlabrada, Serv Radiol, Madrid, Spain
[5] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain
关键词
Childhood; Congenital cataract; Meningioma; Neurofibromatosis type 2; Schwannoma; Wishart; DIAGNOSIS; MANAGEMENT; NF2;
D O I
10.33588/rn.6403.2016355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Neurofibromatosis type 2 (NF2) is a dominantly inherited neuroectodermal syndrome that predispose to the development of tumors of the central and peripheral nervous system. Additional features include eye and skin abnormalities. Case report. A 12-year old male with diagnosis of MF2 according to Baser et al and presentation in childhood was included. A comprehensive bibliographic review of evolution of the diagnostic criteria for NF2 in children was performed. Conclusions. The pattern of presentation of NF2 in childhood differs from adulthood in many aspects. Ophthalmologic and skin manifestations, and not an auditory dysfunction, are the most common initial symptoms in prepuberal-onset NF2. The most frequent symptoms and signs at presentation are posterior subcapsular cataract, skin manifestations as NF2 plaques and/ or peripheral nerve tumors, and neurological dysfunction related to isolated or multiple cranial nerve deficits (other than nerve VIII), brainstem masses or spinal masses. As sensitivity of diagnostic criteria in children is low, those prepuberal patients with congenital or early-onset cataracts and typical skin manifestations of NF2 should be systematically assessed.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [1] Stroke in childhood neurofibromatosis type 2
    Kirkham, Fenella J.
    Keylock, Annette
    Saunders, Dawn E.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (12): : 1199 - 1200
  • [2] Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2
    Ardern-Holmes, Simone L.
    North, Kathryn N.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2011, 13 (06) : 529 - 543
  • [3] Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2
    Simone L. Ardern-Holmes
    Kathryn N. North
    Current Treatment Options in Neurology, 2011, 13 : 529 - 543
  • [4] Ophthalmological spectrum of neurofibromatosis type 2 in childhood
    Mautner, VF
    Hazim, W
    Pohlmann, K
    Berger, R
    Kluwe, L
    Haase, W
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1996, 208 (01) : 58 - 62
  • [5] Characterization of early onset neurofibromatosis type 2
    Matsuo, Muneaki
    Ohno, Kousaku
    Ohtsuka, Fujio
    BRAIN & DEVELOPMENT, 2014, 36 (02): : 148 - 152
  • [6] The various presentations of Neurofibromatosis type 2 [Nf2] in childhood
    Huson, S
    Ruggieri, M
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S69 - S69
  • [7] Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?
    Lascelles, Karine
    Afridi, Shazia
    Siddiqui, Ata
    Hemingway, Cheryl
    Ferner, Rosalie
    Ganesan, Vijeya
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (12): : 1285 - +
  • [8] Posterior circulation ischemic stroke in childhood and neurofibromatosis type 2
    Bonne, Nicolas-Xavier
    Baroncini, Marc
    Aboukais, Rabih
    Lorenz, Mark Brandt
    Broly, Franck
    Dubrulle, Frederique
    Lejeune, Jean-Paul
    Vincent, Christophe
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY EXTRA, 2014, 9 (01) : 22 - 26
  • [9] Neurofibromatosis type 1 in childhood.
    de Vries, P
    JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY AND ALLIED DISCIPLINES, 1998, 39 (05): : 792 - 792
  • [10] NEUROFIBROMATOSIS TYPE-1 IN CHILDHOOD
    LISTERNICK, R
    CHARROW, J
    JOURNAL OF PEDIATRICS, 1990, 116 (06): : 845 - 853